LANOXIN ELX 0.05MG/ML PEDIATRIC DIN 00242713
Health Canada record
| Active ingredient(s) | DIGOXIN .05 MG |
|---|---|
| Dosage form | Liquid |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | C01AA05 DIGOXIN |
| Original market date | 31-Dec-1956 |
| Current status date | 31-Jul-2003 |
| Source | Health Canada DPD |
Establishment licence of the holder
Glaxo Wellcome S.A. — licence , not currently licensed, last inspection rating C (2025-05-09).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing DIGOXIN .05 MG
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 00567892 | CARDOXIN L/S ELIXIR 0.05MG/ML | EVSCO PHARMACEUTICAL, DIVISION OF VÉTOQUINOL U.S.A. | Elixir | DIGOXIN .05 MG | Cancelled Post Market |
| 00004456 | LANOXIN INJ 0.05MG/ML PEDIATRIC | GLAXO WELLCOME INC. | Liquid | DIGOXIN .05 MG | Cancelled Post Market |